JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2011, Vol. 49 ›› Issue (4): 123-128.

• Articles • Previous Articles     Next Articles

Expressions and correlations of hepatoma-derived growth factor and microvascular density in human extra-hepatic cholangio-carcinoma

GUO Sen1,  LIU Yan-feng1, ZHAO Rui1, CUI Xi-jun2, NIU Jun1,CHEN Yu-xin1, WU Xiao-peng1, XU Ke-sen1   

  1. 1. Department of Hepatobiliary Surgery, Qilu Hospital of Shandong University, Jinan 250012, China;
    2. First Department of General Surgery, Wendeng Central Hospital of Weihai, Wendeng 264400, Shandong, China
  • Received:2011-03-04 Online:2011-04-10 Published:2011-04-10

Abstract:

Objective     To investigate expressions of hepatoma-derived growth factor(HDGF) and micro-vascular density(MVD) and their correlations with clinicopathological characteristics and prognosis in patients with extrahepatic cholangio-carcinoma. Methods    Expressions of HDGF and MVD were analyzed in 65 patients after surgery for extra-hepatic cholangio-carcinoma by immunohistochemistry using the avidin-biotin peroxidase complex method,  and then their correlations with clinicopathological characteristics and survival time of patients were analyzed.  ResultsImmunohistochemical results showed positive expression rates of HDGF and MVD were 46.2% and 58.5%, respectively. Spearman rank correlation analysis demonstrated HDGF and MVD expressions had a positive correlation(r=0.279,P=0.024).   Survival analysis showed that the HDGF-positive group had a significantly poorer survival rate than the HDGF-negative group did (23.3% vs 62.9%, P<0.001). Multivariate analysis demonstrated that HDGF expression is an independent prognostic factor.  Conclusions    HDGF expression significantly correlates with MVD and is an independent prognostic factor for human extra-hepatic cholangio-carcinoma. HDGF plays an important role in promoting angiogenesis during the development of extrahepatic cholangio-carcinoma.

Key words: Hepatoma-derived growth factor; Microvascular density; Extrahepatic cholangiocarcinoma; Prognosis

CLC Number: 

  • R735.8
No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!